Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sincera Reproductive Medicine was a Pennsylvania-based fertility clinic and reproductive endocrinology practice focused on infertility evaluation, assisted reproductive technology, and family-building services. Its offerings included in vitro fertilization, intrauterine insemination, egg freezing, egg donation, surrogacy support, genetic testing support, and related reproductive surgical and laboratory services. The practice was formerly known as Abington Reproductive Medicine and had operated in the greater Philadelphia region for more than 30 years. In July 2023, Sincera Reproductive Medicine was acquired by The Prelude Network, with key Sincera locations integrated into and rebranded under Main Line Fertility. As a result, Sincera is best understood today as a legacy clinic brand rather than an independently operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sincera Reproductive Medicine.